Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DermDx is a specialized dermatopathology service provider that offers comprehensive diagnostic solutions for skin-related conditions. Originally established as an independent laboratory group, it was acquired by Aurora Diagnostics in 2007 and subsequently became part of Sonic Healthcare USA in 2019. The company provides expert interpretation of skin biopsies, utilizing advanced histopathology, immunohistochemistry, and molecular diagnostic techniques to assist dermatologists in the accurate diagnosis of skin cancers and inflammatory dermatoses. DermDx operates through various regional centers, such as DermDX New England, and is recognized for its focus on clinical relevance, rapid turnaround times, and a medical leadership model that emphasizes pathologist-to-physician consultation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DermDx.